Abstract
Diabetic retinopathy is the most common complications of diabetes mellitus that, in most occasions, lead to blindness. Multiple evidences linked the serum magnesium, iron and ferritin disturbance with diabetes and its complications. A case–control study was conducted at Makkah Eye Complex, Khartoum, Sudan, to compare the levels of serum magnesium, iron and ferritin in patients with diabetic retinopathy with diabetic patients without diabetic retinopathy (controls). Findings indicate that all patients had type 2 diabetes. The two groups (50 in each arm) were well matched in their basic characteristics. Median (25th–75th interquartile) of serum magnesium in patients with diabetic retinopathy were significantly lower than patients without diabetic retinopathy [1.48 (0.75–1.64) vs. 1.92 (1.4–2.3)mg/dl, P = 0.022]. The median of serum iron and ferritin were lower in cases than control group but did not reach a statistical significance [20.5 (17.2–48.0) vs. 27.0 (16.0–54.0) μg/dl, P = 0.568; 98.0 (45.0–134.75) vs. 101.0 (47.0–161.0) μg/l, P = 0.818]. The duration of diabetes [16.5 (9.3) vs. 11.2 (6.6) years; P = 0.014] and haemoglobin level [13.7 (0.9) vs. 12.5 (2.0) g/dl; P = 0.039] were significantly higher in cases group than control group. A significant inverse correlation was observed between serum magnesium and iron levels. Twenty (40 %) patients had severe non-proliferative diabetic retinopathy with mild macular edema, which is the most prevalent type among the cases group. Hypomagnesaemia among diabetic patients was associated with diabetic retinopathy, while serum iron and ferritin have no significant effect in this setting. Severe non-proliferative diabetic retinopathy with mild macular edema is the prevalent type in this study.
Similar content being viewed by others
References
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103(2):137–149
Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. N Engl J Med 366:1227–1239
Elbagir MN, Eltom MA, Elmahadi EM, Kadam IM, Berne C (1996) A population based study of the prevalence of diabetes and impaired glucose tolerance in adults in northern Sudan. Diabetes Care 19(10):1126–1128
Elbagir MN, Eltom MA, Mahadi EO, Berne C (1995) Pattern of long-term complications in Sudanese insulin-treated diabetic patients. Diabetes Res Clin Pract 30(1):59–67
Mertz W (1981) The essential trace elements. Science 213:1332–1338
Fawcett WJ, Haxby EJ, Male DA (1999) Magnesium: physiology and pharmacology. BJA 83(2):302–320
Sales CH, Pedrosa Lde F (2006) Magnesium and diabetes mellitus: their relation. Clin Nutr 25(4):554–562
Suarez A, Pulido N, Casla A, Casanova B, Arrieta F, Rovira A (1995) Impaired tyrosine kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia 38(11):1262–1270
Winter WE, Bazydlo LA, Harris NS (2014) The molecular biology of human iron metabolism. Lab Med 45(2):92–102
Rajpathak SN, Crandall JP, Wylie-Rosett J, Kabat GC, Rohan TE, Hu FB (2009) The role of iron in type 2 diabetes in humans. Biochim Biophys Acta 1790(7):671–681
Elis A, Ferencz JR, Gilady G, Livne A, Assia EI, Lishner M (2004) Is serum ferritin high in patients with diabetic retinopathy? A controlled study. Endocr Res 30(2):141–147
McNair P, Christiansen C, Madsbad S, Lauritzen E, Faber O, Binder C, Transbøl I (1978) Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes 27(11):1075–1077
Hatwal A, Gujral AS, Bhatia RP, Agrawal JK, Bajpai HS (1989) Association of hypomagnesemia with diabetic retinopathy. Acta Ophthalmol (Copenh) 67(6):714–716
Kundu D, Osta M, Mandal T, Bandyopadhyay U, Ray D, Gautam D (2013) Serum magnesium levels in patients with diabetic retinopathy. J Nat Sci Biol Med 4(1):113–116
Erasmus RT, Olukoga AO, Alanamu RA, Adewoye HO, Bojuwoye B (1989) Plasma magnesium and retinopathy in black African diabetics. Trop Geogr Med 41(3):234–237
Longo-Mbenza B, Mvitu Muaka M, Masamba W, Muizila Kini L, Longo Phemba I, Kibokela Ndembe D, Tulomba Mona D (2014) Retinopathy in non-diabetics, diabetic retinopathy and oxidative stress: a new phenotype in Central Africa? Int J Ophthalmol 7(2):293–301
Mahaba HM, Ben Thabet EA, el-Ghazali S, el-Ebiari H, Abd el-Aziz HF (2000) Magnesium deficiency and other risk factors for diabetic retinopathy. J Egypt Public Health Assoc 75(3–4):323–333
Sheu WH, Chen YT, Lee WJ, Wang CW, Lin LY (2003) A relationship between serum ferritin and the insulin resistance syndrome is present in non-diabetic women but not in non-diabetic men. Clin Endocrinol 58(3):380–385
Canturk Z, Cetinarslan B, Tarkun I, Canturk NZ (2003) Serum ferritin levels in poorly- and well-controlled diabetes mellitus. Endocr Res 29(3):299–306
Abass RM, Hamdan HZ, Elhassan EM, Hamdan SZ, Ali NI, Adam I (2014) Zinc and copper levels in low birth weight deliveries in Medani Hospital, Sudan. BMC Res Notes 7(1):386
Hamdan HZ, Elbashir LM, Hamdan SZ, Elhassan EM, Adam I (2014) Zinc and selenium levels in women with gestational diabetes mellitus at Medani Hospital, Sudan. J Obstet Gynaecol 34(7):567–570
Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT (2003) Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110(9):1677–1682
Scholefield JH, Robinson MH, Bostock K, Brown NS (1998) Serum ferritin. Screening test for colorectal cancer? Dis Colon Rectum 41(8):1029–1031
Sadat-Ali M, Sultan O, Al-Turki H, Alelq A (2011) Does high serum iron level induce low bone mass in sickle cell anemia ? Biometals 24(1):19–22
Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A (2000) Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 294(1–2):1–26
Liamis G, Liberopoulos E, Barkas F, Elisaf M (2014) Diabetes mellitus and electrolyte disorders. World J Clin Cases 2(10):488–496
Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D (2005) American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28:956–962
Quamme GA (2001) Renal handling of magnesium. In: Massry SH, Glassock RJ (eds) Massry and Glassock’s textbook of nephrology, 4th edn. Lippincott Williams & Wilkins, Baltimore, pp 344–350
Barbagallo M, Dominguez L (2007) Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 458(1):40–47
Ihara Y, Yamada Y, Toyokuni S, Miyawaki K, Ban N, Adachi T, Kuroe A, Iwakura T, Kubota A, Hiai H, Seino Y (2000) Antioxidant alpha-tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes. FEBS Lett 473:24–26
Wu Y, Tang L, Chen B (2014) Oxidative stress implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives. Oxid Med Cell Longev 752387
Lin WJ, Kuang HY (2014) Oxidative stress induces autophagy in response to multiple noxious stimuli in retinal ganglion cells. Autophagy 10(10):1692–1701
Ozdemir G, Kılınç M, Ergün Y, Sahin E (2014) Rapamycin inhibits oxidative and angiogenic mediators in diabetic retinopathy. Can J Ophthalmol 49(5):443–449
Weglicki WB, Chmielinska JJ, Tejero-Taldo I, Kramer JH, Spurney CF, Viswalingham K, Lu B, Mak IT (2009) Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia. Magnes Res 22(3):167–173
Kramer JH, Spurney C, Iantorno M, Tziros C, Mak IT, Tejero-Taldo MI, Chmielinska JJ, Komarov AM, Weglicki WB (2009) Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia. Am J Med Sci 338(1):22–27
Hans CP, Chaudhary DP, Bansal DD (2003) Effect of magnesium supplementation on oxidative stress in alloxanic diabetic rats. Magnes Res 16(1):13–19
Olatunji LA, Soladoye AO (2007) Effect of increased magnesium intake on plasma cholesterol, triglyceride and oxidative stress in alloxan-diabetic rats. Afr J Med Med Sci 36(2):155–161
Oba K, Yamashita N, Okazaki K, Sato S, Sasai K, Suzuki T, Nakano H, Netori S (1997) High levels of serum ferritin in elderly patients with non-insulin-dependent diabetes mellitus. Nippon Ronen Igakkai Zasshi 34:305–311
Fernandez-Real JM, Ricart-Engel W, Arroyo E, Balanca R, Casamitjana-Abella R, Cabrero D, Fernandez-Castaner M, Soler J (1998) Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 21:62–68
Pickup JC, Matttock MB, Chusney GD, Burt D (1997) NIDDM as a disease of the innate immune system: association of acute phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286–1292
Abougalambou SS, Abougalambou AS (2014) Risk factors associated with diabetic retinopathy among type 2 diabetes patients at teaching hospital in Malaysia. Diabetes Metab Syndr S1871–4021(14):00031–00039
Scanlon PH, Aldington SJ, Stratton IM (2013) Epidemiological issues in diabetic retinopathy. Middle East Afr J Ophthalmol 20(4):293–300
Bahar A, Kashi Z, Ahmadzadeh Amiri A, Nabipour M (2013) Association between diabetic retinopathy and hemoglobin level. Caspian J Intern Med 4(4):759–762
Acknowledgments
The authors are very grateful to all the patients for their co-operation, and the working staff in Makkah Eye Complex.
Funding
The study was funded by Zahybash for trading, Khartoum, Sudan.
Competing interests
The authors declare that they have no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hamdan, H.Z., Nasser, N.M., Adam, A.M. et al. Serum Magnesium, Iron and Ferritin Levels in Patients with Diabetic Retinopathy Attending Makkah Eye Complex, Khartoum, Sudan. Biol Trace Elem Res 165, 30–34 (2015). https://doi.org/10.1007/s12011-015-0236-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-015-0236-4